NSAIDs in Coronary Artery Disease Patients
NSAIDs in Coronary Artery Disease Patients
Introduction:

 Different groups already showed in retrospective subgroup analyses, that there is an
 increased risk for cardiovascular events in patients on a simultaneous ASA/NSAID treatment.

 Methods:

 Light-Transmission aggregometry

 Hypothesis:

 Simultaneous administration of different NSAIDs and ASA impair the platelet inhibiting effect
 of ASA.
Inclusion Criteria:

 -  Patients on a simultaneous ASA, NSAID treatment

 -  > 18 years

 Exclusion Criteria:

 -  unconsciousness, not able to consent

 -  reanimation, cardiac shock